Back to Search
Start Over
Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study
- Source :
- Archives of Cardiovascular Diseases
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Background: The coronavirus disease 2019 (COVID-19) pandemic has led to a public health crisis. Only limited data are available on the characteristics and outcomes of patients hospitalized for COVID-19 in France. Aims: To investigate the characteristics, cardiovascular complications and outcomes of patients hospitalized for COVID-19 in France. Methods: The Critical COVID-19 France (CCF) study is a French nationwide study including all consecutive adults with a diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection hospitalized in 24 centres between 26 February and 20 April 2020. Patients admitted directly to intensive care were excluded. Clinical, biological and imaging parameters were systematically collected at hospital admission. The primary outcome was in-hospital death. Results: Of 2878 patients included (mean ± SD age 66.6 ± 17.0 years, 57.8% men), 360 (12.5%) died in the hospital setting, of which 7 (20.7%) were transferred to intensive care before death. The majority of patients had at least one (72.6%) or two (41.6%) cardiovascular risk factors, mostly hypertension (50.8%), obesity (30.3%), dyslipidaemia (28.0%) and diabetes (23.7%). In multivariable analysis, older age (hazard ratio [HR] 1.05, 95% confidence interval [CI] 1.03−1.06; P < 0.001), male sex (HR 1.69, 95% CI 1.11−2.57; P = 0.01), diabetes (HR 1.72, 95% CI 1.12−2.63; P = 0.01), chronic kidney failure (HR 1.57, 95% CI 1.02−2.41; P = 0.04), elevated troponin (HR 1.66, 95% CI 1.11−2.49; P = 0.01), elevated B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide (HR 1.69, 95% CI 1.0004−2.86; P = 0.049) and quick Sequential Organ Failure Assessment score ≥ 2 (HR 1.71, 95% CI 1.12−2.60; P = 0.01) were independently associated with in-hospital death. Conclusions: In this large nationwide cohort of patients hospitalized for COVID-19 in France, cardiovascular comorbidities and risk factors were associated with a substantial morbi-mortality burden.
- Subjects :
- Male
Pediatrics
CAD, coronary artery disease
Comorbidity
030204 cardiovascular system & hematology
qSOFA, quick Sequential Organ Failure Assessment
0302 clinical medicine
Risk Factors
Hospital Mortality
030212 general & internal medicine
Cardiovascular risk factors
COVID-19, coronavirus disease 2019
Aged, 80 and over
Hazard ratio
General Medicine
Middle Aged
ICU, intensive care unit
CT, computed tomography
Death
Intensive Care Units
Characteristics
Treatment Outcome
Cardiovascular Diseases
Hypertension
Cohort
Female
France
Cardiology and Cardiovascular Medicine
CCF, Critical COVID-19 France
Adult
medicine.medical_specialty
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
Article
03 medical and health sciences
Intensive care
Diabetes mellitus
Diabetes Mellitus
medicine
Humans
Obesity
Pandemics
Aged
Dyslipidemias
Inpatients
SARS-CoV-2
business.industry
Public health
COVID-19
medicine.disease
Confidence interval
Kidney Failure, Chronic
business
Subjects
Details
- ISSN :
- 18752136
- Volume :
- 114
- Database :
- OpenAIRE
- Journal :
- Archives of Cardiovascular Diseases
- Accession number :
- edsair.doi.dedup.....4a3431d776bda2f9162207d503e72c68